Back to search
Carnitine Palmitoyltransferase II Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Carnitine Palmitoyltransferase II Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Carnitine Palmitoyltransferase II Deficiency trials you may qualify forExpanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.
The main goal of this study is to evaluate the effects of triheptanoin versus Medium-chain Triglycerides (MCT) on frequency of Major Clinical Events (MCEs).
Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…